"Novartis is delighted about today’s announcement and the difference this therapy will make to patients in Australia," said Lauren Carey, general manager Oncology and country president, Novartis Australia and New Zealand. …
Latest Video
New Stories
-
Bluebird Bio confirms price of its first gene therapy
June 17, 2019 - - Latest News -
Where will the government find the billions for new listings?
June 17, 2019 - - Latest News -
Will it require another 'Factor F' program?
June 17, 2019 - - Latest News -
PBAC - May 'intracycle' outcomes
June 17, 2019 - - Latest News -
What is the 'opportunity cost' of doing nothing?
June 17, 2019 - - Latest News -
Lack of investment driving back-room deals
June 14, 2019 - - Latest News -
New technologies exposing flaws in HTA
June 14, 2019 - - Latest News